• 1
    Glueck CJ, Glueck HI, Greenfield D, et al. 1994. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg–Perthes disease. Pediatr Res 35:383388.
  • 2
    Kenet G, Ezra E, Wientroub S, et al. 2008. Perthes' disease and the search for genetic associations: collagen mutations, Gaucher's disease and thrombophilia. J Bone Joint Surg Br 90:15071511.
  • 3
    Glueck CJ, Freiberg RA, Crawford A, et al. 1998. Secondhand smoke, hypofibrinolysis, and Legg–Perthes disease. Clin Orthop Relat Res 352:159167.
  • 4
    Glueck CJ, Fontaine RN, Gruppo R, et al. 1999. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res 366:133146.
  • 5
    Dahlback B, Zoller B, Hillarp A. 1996. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis. Haemostasis 26:301314.
  • 6
    Balasa VV, Gruppo RA, Glueck CJ, et al. 1999. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost 81:739744.
  • 7
    Eldridge J, Dilley A, Austin H, et al. 2001. The role of protein C, protein S, and resistance to activated protein C in Legg–Perthes disease. Pediatrics 107:13291334.
  • 8
    Vosmaer A, Pereira RR, Koenderman JS, et al. 2010. Coagulation abnormalities in Legg–Calve–Perthes disease. J Bone Joint Surg Am 92:121128.
  • 9
    Balasa VV, Gruppo RA, Glueck CJ, et al. 2004. Legg–Calve–Perthes disease and thrombophilia. J Bone Joint Surg Am 86-A:26422647.
  • 10
    Arruda VR, Belangero WD, Ozelo MC, et al. 1999. Inherited risk factors for thrombophilia among children with Legg–Calve–Perthes disease. J Pediatr Orthop 19:8487.
  • 11
    Hayek S, Kenet G, Lubetsky A, et al. 1999. Does thrombophilia play an aetiological role in Legg–Calve–Perthes disease? J Bone Joint Surg Br 81:686690.
  • 12
    Thakkinstian A, McKay GJ, McEvoy M, et al. 2011. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 173:13651379.
  • 13
    Thakkinstian A, Thompson JR, Minelli C, et al. 2009. Choosing between per-genotype, per-allele, and trend approaches for initial detection of gene–disease association. J Appl Stat 36:633646.
  • 14
    Sterne JA, Gavaghan D, Egger M. 2000. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53:11191129.
  • 15
    Sterne JA, Egger M, Smith GD. 2001. Investigating and dealing with publication and other biases. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group. p 189208.
  • 16
    Sirvent N, Fisher F, El Hayek T, et al. 2000. Absence of congenital prethrombotic disorders in children with Legg–Perthes disease. J Pediatr Orthop B 9:2427.
  • 17
    Szepesi K, Posan E, Harsfalvi J, et al. 2004. The most severe forms of Perthes' disease associated with the homozygous Factor V Leiden mutation. J Bone Joint Surg Br 86:426429.
  • 18
    Lopez-Franco M, Gonzalez-Moran G, De Lucas JC Jr, et al. 2005. Legg–Perthes disease and heritable thrombophilia. J Pediatr Orthop 25:456459.
  • 19
    Yilmaz D, Karapinar L, Karapinar B, et al. 2005. Evaluation of anticoagulant system in Turkish children with Perthes disease. Pediatr Int 47:4348.
  • 20
    Glueck CJ, Brandt G, Gruppo R, et al. 1997. Resistance to activated protein C and Legg–Perthes disease. Clin Orthop Relat Res 338:139152.
  • 21
    Sanders LLO, Braga MB Jr, Cima CWM, et al. 2009. Leiden's V-factor in Legg–Calve–Perthes disease. Acta Ortop Bras 17:4042.
  • 22
    Garcia Mata S, Ardanaz Aicua E, Hidalgo Ovejero A, et al. 2000. Legg–Calve–Perthes disease and passive smoking. J Pediatr Orthop 20:326330.
  • 23
    Daniel AB, Shah H, Kamath A, et al. 2012. Environmental tobacco and wood smoke increase the risk of Legg–Calve–Perthes disease. Clin Orthop Relat Res 470:23692375.
  • 24
    Glueck CJ, Crawford A, Roy D, et al. 1996. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg–Perthes disease. J Bone Joint Surg Am 78:313.
  • 25
    Segers K, Dahlback B, Nicolaes GA. 2007. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost 98:530542.
  • 26
    Koeleman BP, van Rumpt D, Hamulyak K, et al. 1995. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 74:580583.
  • 27
    Poort SR, Rosendaal FR, Reitsma PH, et al. 1996. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:36983703.
  • 28
    Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111113.
  • 29
    Thakkinstian A, McElduff P, D'Este C, et al. 2005. A method for meta-analysis of molecular association studies. Stat Med 24:12911306.